Cancer Vaccines and Immunotherapy
A section of Vaccines (ISSN 2076-393X).
Keywords
- Tumor immunology
- Immune checkpoint inhibitors
- T cells
- Animal models
- Immunophenotype
- Mass cytometry
- Immune signature
- Immune score
- Immune cells
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Therapeutic Vaccine against Cancer (Deadline: 30 April 2021)
- Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment (Deadline: 30 April 2021)
- Tumor Immunotherapy (Deadline: 31 May 2021)
- Dendritic Cell Immunotherapies: An Opportunity in the Fight against Cancer and Beyond (Deadline: 31 May 2021)
- Clinical Effect and Immunologic Response after Dendritic Cell-Based Immunotherapy (Deadline: 31 May 2021)
- Cancer Immunotherapy and Immune Related Cardiac Complications (Deadline: 31 August 2021)
- Cancer Immunotherapy and Vaccines Research (Deadline: 31 August 2021)
- Cell-Mediated Immunity and Cancer Vaccines (Deadline: 30 September 2021)
- New Sights in Cancer Therapy and Covid Vaccination for Cancer Patients (Deadline: 31 October 2021)
- New Sights in Vaccines and Immunotherapy for Liver Cancer (Deadline: 31 December 2021)
- Advances in Cancer Immunology (Deadline: 31 December 2021)
- The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy (Deadline: 1 March 2022)
